Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.100 | None | 0.974 | 2 | 0 | 1989 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
disease | 0.100 | None | 0.923 | 2 | 0 | 1994 | 2018 | ||||||||
|
CD38 molecule | 0.407 | 0.885 | 2.3E-06 |
|
disease | 0.100 | None | 0.971 | 2 | 0 | 1986 | 2019 | ||||||||
|
CD19 molecule | 0.430 | 0.885 | 0.90 |
|
disease | 0.100 | None | 0.971 | 2 | 0 | 1992 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.100 | None | 1.000 | 2 | 0 | 2008 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.100 | None | 1.000 | 2 | 0 | 1992 | 2019 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 2 | 0 | 2002 | 2018 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 2 | 0 | 1993 | 2019 | ||||||||
|
MCL1 apoptosis regulator, BCL2 family member | 0.430 | 0.808 | 0.96 |
|
disease | 0.100 | None | 0.909 | 2 | 0 | 2000 | 2019 | ||||||||
|
signal transducer and activator of transcription 5B | 0.442 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
LIM domain only 2 | 0.585 | 0.654 | 0.16 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1991 | 2019 | ||||||||
|
GATA binding protein 1 | 0.483 | 0.808 | 0.95 |
|
disease | 0.100 | None | 0.963 | 1 | 0 | 1995 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.100 | None | 0.944 | 1 | 0 | 1990 | 2019 | ||||||||
|
homeobox A cluster | 0.599 | 0.654 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1992 | 2019 | |||||||||
|
T cell leukemia homeobox 1 | 0.644 | 0.308 | 0.74 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1994 | 2015 | ||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1989 | 2017 | ||||||||
|
transcription factor 3 | 0.476 | 0.846 | 2.6E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1992 | 2020 | ||||||||
|
killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1 | 0.475 | 0.769 | 8.4E-14 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
menin 1 | 0.444 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
TAL bHLH transcription factor 1, erythroid differentiation factor | 0.505 | 0.731 | 0.57 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1991 | 2018 | ||||||||
|
alanyl aminopeptidase, membrane | 0.462 | 0.769 | 3.7E-09 |
|
disease | 0.100 | None | 0.900 | 1 | 0 | 1991 | 2012 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
lysine acetyltransferase 6A | 0.560 | 0.769 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1997 | 2017 | ||||||||
|
PBX homeobox 1 | 0.534 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0.917 | 1 | 0 | 1992 | 2017 | ||||||||
|
neural cell adhesion molecule 1 | 0.415 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.882 | 1 | 0 | 1988 | 2019 |